RAD51C and hypoparathyroidism-retardation-dysmorphism syndrome: One patient with a P/LP variant in RAD51C was included in a poly ADP-ribose polymerase inhibitor (PARPi) clinical trial that required documentation of a P/LP variant in a homologous recombination deficiency (HRD) gene for enrollment.